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1. Introduction 
A single dose of D-erythrose (300 mg) injected 
subcutaneously into rats has recently been found to 
produce a mild hyperglycemia in the injected animals 
[l] . Results of preliminary experiments did not ex- 
clude the possibility, among others, that the non- 
availability of active insulin in the circulation might 
be involved in the D-erythrose-induced hyperglycemia., 
D-Mannoheptulose has been found to produce a 
transient hyperglycemia in rats [2] , and to abolish 
the glucose-induced insulin release from pieces of 
pancreas [3,4] as well as from isolated islets of Langer- 
hans [5] . D-Mannoheptulose has been found to inhibit 
glucokinase and hexokinase of rat liver [6] and of 
-other tissues (cited in [6]) and competitively inhibits 
the phosphorylation of glucose in homogenates of 
isolated islets of Langerhans [7] . These findings led 
to the suggestion that glucose phosphorylation in the 
/J-cells may be a rate-determining step in the process of 
insulin release stimulated by glucose [6] . 
This suggestion also led us to examine the effect of 
D-erythrose on glycolysis. Human blood cells were 
chosen for this study. D-Erythrose has been found to 
have no effect on lactate production in blood cells 
in vitro. While no measurable effect of D-manno- 
heptulose on the ATP level and the rate of glucose 
disappearence from blood in vitro was found, the 
heptulose markedly inhibited lactate formation in the 
blood cells. 
2. Materials and methods 
Fresh blood was obtained from common blood- 
bank donors, by venipuncture with heparin as anti- 
coagulant. Blood stored on acid-citrate-dextrose solu- 
tion (U.S.P. formula A) was obtained from the Blood 
Bank of the Hadassah Medical School, and used with- 
in 3 weeks of storage. Hemoglobin-free hemolysates 
were obtained from cells of stored blood with the aid 
of diethylaminoethyl (DEAE) cellulose [8]. 
D-Mannoheptulose was the gift of Prof. E. Simon, 
The Weizmann Institute of Science, Rehovot, Israel. 
D-Erythrose was prepared from 2,4-O-ethylidene-D- 
erythrose [9] by acid hydrolysis, neutralization with 
barium carbonate, and careful deionization with a 
mixed-bed ion exchange resin. D-Erythrose was 
estimated by its oxidation with periodate and measure- 
ment of the formaldehyde formed with chromotropic 
acid [ lo] . 
Lactate [ 1 l] and pyruvate [ 121 were measured 
with lactic dehydrogenase. Glucose was estimated 
with glucose oxidase [ 131 and ATP with luciferase 
of fireflies’ tails [ 141. Hexokinase activity was meas- 
ured with glucosed-phosphate dehydrogenase [151 
and expressed as E.cmole glucosed-phosphate pro- 
duced/mg protein/min. Protein was determined with 
the Folin phenol reagent [ 161. 
Hexokinase was separated by vertica1 starch-gel 
electrophoresis [ 171 and detected by the fluorescence 
of NADPH, [18]. 
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3. Results 
Experiments with low D-erythrose concentration 
in whole blood (0.5 mM) and further experiments 
with high concentrations (15 mM, fig. 1) showed the 
tetrose to have no effect on blood cell lactate produc- 
tion in vitro. (D-Erythrose has also been found to 
have no effect on lactate production in rat whole blood 
in vitro). 
D-Mannoheptulose (0.5 mM), on the other hand, 
showed a slight though significant inhibition of lactate 
production. Lactate formation in human fresh whole 
blood in the absence and in the presence of increasing 
added amounts of D-mannoheptulose (fig. 2) indicates 
that the heptulose exerts an inhibitory effect on 
lactate production in blood cells. This inhibition is 
proportional to the heptulose concentration and be- 
comes prominent after the first 6 hr of incubation. 
No significant effect of D-mannoheptulose on pyruvate 
formation in blood cells was found. The rate of glu- 
case disappearance from whole blood and the ATP 
level in the blood cells are not affected by the presence 
of the heptulose (fig. 3). The results presented in fig. 
3 suggest hat the delayed effect of the keto-heptose 
on lactate production in whole blood might be related 
to a slow passage of the heptulose into the cells, to 
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Fig. 1. Lactate production in human whole blood, in v&-o, in 
the presence of added D-erythrose. Isotonic D-erythrose or 
sucrose solution was added to whole blood to make a final 
concentration of 15 mM. Blood with D-erythrose -, 
with sucrose e-4. 
Fig. 2. Lactate production in human blood in vitro in the 
presence of added D-mannoheptulose. Isotonic D-manno- 
heptulose solution was added to whole blood to make the 
final concentration required. Final volumes of blood were 
adjusted with isotonic sucrose. D-Mannoheptulose concentra- 
tion: None l ; 0.5 mM X ; 5 mM A; 15 mM o. 
the low accumulation of an active heptulose-derivative 
(either in the cells, or in the cell membrane), or to 
other factors. 
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Fig. 3. Glucose and ATP content of whole blood in the pres- 
ence and in the absence of added D-mannoheptulose. Blood 
made 15 mM with mannoheptulose A, or sucrose o, ATP -. 
Blood made 30 mM with D-mannoheptulose o, or sucrose q ,
plucose----. 
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Fig. 4. Chromatographic separation of blood cell hexokinase 
on DEAE cellulose. Chromatography was performed at 4’ at 
a rate of 40 ml/hr. Fractions of 14 ml were collected. The en- 
zyme in the eluant was reprecipitated with ammonium sulfate 
and dialysed against 0.01 mM phosphate buffer. 
Blood cell hexokinase was purified as follows. 
Hexokinase of hemoglobin-free hemolysates [8] was 
separated at 40-55% ammonium sulfate saturation at 
4”. The precipitate was dissolved in 0.01 M phosphate 
buffer pH 7.0, containing EDTA-Na, (5 mM), fl-mer- 
captoethanol(5 mM) and glucose (10 mM), and 
dialysed against the same buffer. The enzyme was 
adsorbed on a DEAE cellulose column and eluted 
with a linear 0.0-0.6 M potassium chloride (2L) 
gradient. The enzyme came off the column as a single 
fraction (fig. 4) at 0.09-0.14 M potassium chloride. 
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Fig. 5. Blood cell hexokinase activity at 45O. Hexokinase in 
100 mM glucose -; in 10 mM glucose -. 
Table 1 
Blood cell hexokinase activity in the presence of 15 mM man- 
noheptulose. 
ATP mM 
pmole G6P formed/l0 min 
MH +MH 
Inhibition (%) 
5.0 0.710 0.630 11.0 
2.5 0.690 0.625 9.5 
1.25 0.510 0.460 9.5 
0.62 0.370 0.240 35.0 
0.31 0.144 0.048 67.0 
0.16 0.067 0.019 71.0 
Reaction mixture (1.0 ml): phosphate 0.7 mM (pH 7.6);glw 
case, 25 mM; D-mannoheptulose 15 mM; NADP, 0.25 mM; 
ATP, see the table; MgCl2, 5.0 mM; mercaptoethanol, 5.0 
mM; G-6-P dehydrogenase 0.3 cc; hexokinase, 0.1 ml. 
By this stage the enzyme had been purified 6900-fold. 
The hexokinase of blood cells separated on DEAE 
cellulose has a pH optimum of 7.0-8.5, an electro- 
phoretic migration in starch gel as that of hexokinase 
II of rat liver [ 171 , and like this enzyme is inactivated 
in 10 mM glucose at 45”, whereas it is stable under the 
same conditions in 100 mM glucose (fig. 5). The blood 
enzyme has an apparent K,,, for glucose of 0.24 mM 
and for ATP of 0.76 mM. 
The enzymatic activity of blood cell hexokinase in 
0.7 mM phosphate buffer, 25 mM glucose, in the 
absence and in the presence of varying ATP concen- 
trations (table l), indicates that at 15 mM manno- 
heptulose the inhibitory effect of the heptulose is in- 
versely proportional to the ATP concentration. At 
0.15-0.3 mM ATP, hexokinase activity is about 70% 
inhibited. 
D-Erythrose was found to have practically no 
effect on blood cell or yeast (Boehringer) hexokinase 
activity. 
Previous work showed the inhibitory effect of 
D-mannoheptulose on glucose phosphorylation in 
homogenized islets of Langerhans to be inversely pro- 
portional to glucose concentration [7] . Extracts of 
mouse islets did not show evidence for the presence 
of glucokinase and ‘it appears unlikely therefore that 
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ghtcokinase is responsible for the increased rate of 
glucose oxidation and insulin release’ [ 191 . Glucose 
oxidation, like release of insulin, was strongly in- 
hibited by mannoheptulose but not by phlorhizin. It 
has later also been suggested that ‘the rate of glucose 
oxidation in islets may be influenced by factors other 
than the rate of glucose phosphorylation’ [20]. 
D-Mannoheptulose has been shown to inhibit 
lactate formation in blood cells (fig. 2) with no meas- 
urable concomitant change in the rate of glucose dis 
appearance from the blood (fig. 3), in accordance with 
the finding that the inhibitory effect of mannoheptulose 
on blood cell hexokinase is inversely proportional to 
the ATP concentration. It also accords with the fact 
that no change of the ATP content of the cells is 
measurable before the glucose level of these cells 
reaches the limit of analysis (fig. 3). These results in- 
dicate that mannoheptulose may inhibit glycolysis at 
a stage beyond the phosphorylation of glucose. 
The pentose phosphate shunt is operative in the 
blood cells [21] . The possibility that mannoheptulose 
partly effects lactate production by modifying this 
metabolic pathway cannot be excluded. 
The finding that D-erythrose has no effect on lac- 
tate production in human blood suggests, to the extent 
that deductions can be made from the metabolism of 
human (and rat) blood cells in vitro to the intact rat, 
that glycolysis seems not to be involved in the D-ery- 
throse-induced hyperglycemia in the rat. 
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